Temozolomide treatment combined with AZD3463 shows synergistic effect in glioblastoma cells.
Goker Bagca B, Ozates NP, Asik A, Caglar HO, Gunduz C, Biray Avci C.
Biochem Biophys Res Commun · journal article · DOI 10.1016/j.bbrc.2020.10.058 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för AZD3463. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
8 träffarEffects of rapamycin and AZD3463 combination on apoptosis, autophagy, and cell cycle for resistance control in breast cancer.
Ozates NP, Soğutlu F, Lerminoglu F, Demir B, Gunduz C, Shademan B, Avci CB.
Life Sci · journal article · DOI 10.1016/j.lfs.2020.118643AZD3463, an IGF-1R inhibitor, suppresses breast cancer metastasis to bone via modulation of the PI3K-Akt pathway.
Hu GF, Wang C, Hu GX, Wu G, Zhang C, Zhu W, Chen C, Gu Y, Zhang H, Yang Z.
Ann Transl Med · research-article; journal article · DOI 10.21037/atm.2020.02.110Combination of Salinomycin and AZD3463 Reveals Synergistic Effect on Reducing the Viability of T98G Glioblastoma Cells.
Asik A, Ay NPO, Bagca BG, Caglar HO, Gunduz C, Avci CB.
Anticancer Agents Med Chem · journal article · DOI 10.2174/1871520620666200721121517Correction: The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia.
Moharram SA, Shah K, Khanum F, Rönnstrand L, Kazi JU.
Blood Cancer J · published erratum; correction · DOI 10.1038/s41408-019-0214-8The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia.
Moharram SA, Shah K, Khanum F, Rönnstrand L, Kazi JU.
Blood Cancer J · letter; research support, non-u.s. gov't · DOI 10.1038/s41408-018-0169-1Novel ALK inhibitor AZD3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis.
Wang Y, Wang L, Guan S, Cao W, Wang H, Chen Z, Zhao Y, Yu Y, Zhang H, Pang JC, Huang SL, Akiyama Y, Yang Y, Sun W, Xu X, Shi Y, Zhang H, Kim ES, Muscal JA, Lu F, Yang J.
Sci Rep · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1038/srep19423Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK Pathways.
Sampson VB, Vetter NS, Kamara DF, Collier AB, Gresh RC, Kolb EA.
PLoS One · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1371/journal.pone.0142704